Clozapine use in schizophrenia linked to notably less insomnia compared to other antipsychotics Dr. Kamal Kant Kohli28 April 2023 3:00 AM ISTUSA: Patients with schizophrenia treated with clozapine may experience significantly less insomnia than those treated with other antipsychotics, a new...
Excitatory brain stimulation remarkably improves negative schizophrenia symptoms, JAMA study. Dr. Shivi Kataria30 Jun 2022 9:45 AM ISTVery few therapeutic options are considered effective for negative symptoms in schizophrenia have a detrimental impact on functional outcomes and...
Topiramate effective as add-on therapy for weight loss in schizophrenia Dr. Shivi Kataria8 March 2022 9:00 AM ISTSouth Asians are prone to more metabolic disorders and thus the effects of schizophrenia per se and its therapy on metabolic profile of an individual...
Pimavanserin useful in tackling negative symptoms in schizophrenia, Lancet study. Dr. Shivi Kataria3 Feb 2022 8:32 AM ISTNegative symptoms of schizophrenia are associated with adverse clinical outcomes, but there are few effective treatments. In the January issue of The...
Color painting based paradigm helps predict schizophrenia severity Dr. Nandita Mohan22 Nov 2021 3:30 PM ISTIndividuals with psychiatric disorders perceive the world differently. A recent study published in BMC psychiatry by Hui Shen et al., has shown that a...
Medical Bulletin 19/November/2021 Dr. Nandita Mohan19 Nov 2021 3:47 PM ISTHere are top Health stories of the dayAbnormal predialysis potassium increase death riskHemodialysis patients rely mainly on potassium removal during...
Color paintings useful in diagnosing and prognosticating schizophrenia: BMC study Dr. Shivi Kataria17 Nov 2021 9:00 AM ISTIndividuals with psychiatric disorders perceive the world differently. A recent study published in BMC psychiatry by Hui Shen et al., has shown that a...
"Prolactin-increasing" antipsychotics tied to breast cancer in female schizophrenics, Lancet study. Dr. Shivi Kataria15 Oct 2021 10:49 AM ISTBreast cancer is more common in female patients with schizophrenia than in the general population. It is not known whether treatment with...
Microglia activation may underlie schizophrenia progression, Study. Dr. Shivi Kataria28 Sept 2021 6:45 PM ISTMicroglia are the resident immune cells in the CNS and major mediators of neuroinflammation. Microglial activation has been proposed to contribute to...
Vitamin D deficiency during childhood tied to mental disorders in future, study. Dr. Shivi Kataria30 Aug 2021 9:00 AM ISTOver the last half century, a body of convergent evidence has accumulated linking disruption of early brain development with an increased risk of...
Young schizophrenics at highest suicide risk, finds JAMA study Dr. Shivi Kataria2 Jun 2021 8:15 AM ISTSuicide is a leading cause of mortality among people with schizophrenia. In contrast to the general population, in which suicide risk increases...
Study finds no structural difference between brains of treatment-responsive and treatment-resistant schizophrenia patients Dr. Shivi Kataria22 April 2021 1:30 AM ISTNearly one-third patients with schizophrenia do not respond to first-line anti-psychotics. This warrants an early diagnosis of this...
